Matches in SemOpenAlex for { <https://semopenalex.org/work/W2932069706> ?p ?o ?g. }
- W2932069706 endingPage "8489" @default.
- W2932069706 startingPage "8480" @default.
- W2932069706 abstract "Among the repertoire of immunoregulatory proteins encoded by myxoma virus, M013 is a viral homologue of the viral pyrin domain-only protein (vPOP) family. In myeloid cells, M013 protein has been shown to inhibit both the inflammasome and NF-κB signaling pathways by direct binding to ASC1 and NF-κB1, respectively. In this study, a three-dimensional homology model of the M013 pyrin domain (PYD) was built based on similarities to known PYD structures. A distinctive feature of the deduced surface electrostatic map of the M013 PYD is the presence of a negatively region consisting of numerous aspartate and glutamate residues in close proximity. Single-site mutations of aspartate and glutamate residues reveal their role in interactions with ASC-1. The biological significance of charge complementarity in the M013–ASC-1 interaction was further confirmed by functional assays of caspase-1 activation and subsequent secretion of cytokines. M013 also has a unique 33-residue C-terminal tail that follows the N-terminal PYD, and it is enriched in positively charged residues. Deletion of the tail of M013 significantly inhibited the interactions between M013 and NF-κB1, thus compromising the ability of the viral protein to suppress the secretion of pro-inflammatory cytokines. These results demonstrate that vPOP M013 exploits distinct structural motifs to regulate both the inflammasome and NF-κB pathways. Among the repertoire of immunoregulatory proteins encoded by myxoma virus, M013 is a viral homologue of the viral pyrin domain-only protein (vPOP) family. In myeloid cells, M013 protein has been shown to inhibit both the inflammasome and NF-κB signaling pathways by direct binding to ASC1 and NF-κB1, respectively. In this study, a three-dimensional homology model of the M013 pyrin domain (PYD) was built based on similarities to known PYD structures. A distinctive feature of the deduced surface electrostatic map of the M013 PYD is the presence of a negatively region consisting of numerous aspartate and glutamate residues in close proximity. Single-site mutations of aspartate and glutamate residues reveal their role in interactions with ASC-1. The biological significance of charge complementarity in the M013–ASC-1 interaction was further confirmed by functional assays of caspase-1 activation and subsequent secretion of cytokines. M013 also has a unique 33-residue C-terminal tail that follows the N-terminal PYD, and it is enriched in positively charged residues. Deletion of the tail of M013 significantly inhibited the interactions between M013 and NF-κB1, thus compromising the ability of the viral protein to suppress the secretion of pro-inflammatory cytokines. These results demonstrate that vPOP M013 exploits distinct structural motifs to regulate both the inflammasome and NF-κB pathways." @default.
- W2932069706 created "2019-04-11" @default.
- W2932069706 creator A5015057310 @default.
- W2932069706 creator A5034744182 @default.
- W2932069706 creator A5038398748 @default.
- W2932069706 creator A5040591138 @default.
- W2932069706 creator A5041557949 @default.
- W2932069706 creator A5081401643 @default.
- W2932069706 date "2019-05-01" @default.
- W2932069706 modified "2023-09-30" @default.
- W2932069706 title "Myxoma virus M013 protein antagonizes NF-κB and inflammasome pathways via distinct structural motifs" @default.
- W2932069706 cites W1484911577 @default.
- W2932069706 cites W1584824123 @default.
- W2932069706 cites W1963739393 @default.
- W2932069706 cites W1966625479 @default.
- W2932069706 cites W1981295860 @default.
- W2932069706 cites W1983072212 @default.
- W2932069706 cites W1989893709 @default.
- W2932069706 cites W2008202400 @default.
- W2932069706 cites W2009503816 @default.
- W2932069706 cites W2009523990 @default.
- W2932069706 cites W2010430257 @default.
- W2932069706 cites W2016212226 @default.
- W2932069706 cites W2022304956 @default.
- W2932069706 cites W2034940658 @default.
- W2932069706 cites W2036007039 @default.
- W2932069706 cites W2045525369 @default.
- W2932069706 cites W2047423808 @default.
- W2932069706 cites W2059419250 @default.
- W2932069706 cites W2062517636 @default.
- W2932069706 cites W2080594285 @default.
- W2932069706 cites W2084438609 @default.
- W2932069706 cites W2115167726 @default.
- W2932069706 cites W2115668602 @default.
- W2932069706 cites W2127310510 @default.
- W2932069706 cites W2127322768 @default.
- W2932069706 cites W2142805130 @default.
- W2932069706 cites W2147199713 @default.
- W2932069706 cites W2148119611 @default.
- W2932069706 cites W2164199283 @default.
- W2932069706 cites W2167340762 @default.
- W2932069706 cites W2170936782 @default.
- W2932069706 cites W2606022266 @default.
- W2932069706 cites W2763467392 @default.
- W2932069706 doi "https://doi.org/10.1074/jbc.ra118.006040" @default.
- W2932069706 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6544859" @default.
- W2932069706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30940649" @default.
- W2932069706 hasPublicationYear "2019" @default.
- W2932069706 type Work @default.
- W2932069706 sameAs 2932069706 @default.
- W2932069706 citedByCount "8" @default.
- W2932069706 countsByYear W29320697062019 @default.
- W2932069706 countsByYear W29320697062020 @default.
- W2932069706 countsByYear W29320697062021 @default.
- W2932069706 countsByYear W29320697062022 @default.
- W2932069706 countsByYear W29320697062023 @default.
- W2932069706 crossrefType "journal-article" @default.
- W2932069706 hasAuthorship W2932069706A5015057310 @default.
- W2932069706 hasAuthorship W2932069706A5034744182 @default.
- W2932069706 hasAuthorship W2932069706A5038398748 @default.
- W2932069706 hasAuthorship W2932069706A5040591138 @default.
- W2932069706 hasAuthorship W2932069706A5041557949 @default.
- W2932069706 hasAuthorship W2932069706A5081401643 @default.
- W2932069706 hasBestOaLocation W29320697061 @default.
- W2932069706 hasConcept C139174496 @default.
- W2932069706 hasConcept C159047783 @default.
- W2932069706 hasConcept C170493617 @default.
- W2932069706 hasConcept C187831198 @default.
- W2932069706 hasConcept C2522874641 @default.
- W2932069706 hasConcept C2777209026 @default.
- W2932069706 hasConcept C2779745803 @default.
- W2932069706 hasConcept C2780879997 @default.
- W2932069706 hasConcept C49039625 @default.
- W2932069706 hasConcept C54355233 @default.
- W2932069706 hasConcept C55493867 @default.
- W2932069706 hasConcept C86803240 @default.
- W2932069706 hasConcept C95444343 @default.
- W2932069706 hasConceptScore W2932069706C139174496 @default.
- W2932069706 hasConceptScore W2932069706C159047783 @default.
- W2932069706 hasConceptScore W2932069706C170493617 @default.
- W2932069706 hasConceptScore W2932069706C187831198 @default.
- W2932069706 hasConceptScore W2932069706C2522874641 @default.
- W2932069706 hasConceptScore W2932069706C2777209026 @default.
- W2932069706 hasConceptScore W2932069706C2779745803 @default.
- W2932069706 hasConceptScore W2932069706C2780879997 @default.
- W2932069706 hasConceptScore W2932069706C49039625 @default.
- W2932069706 hasConceptScore W2932069706C54355233 @default.
- W2932069706 hasConceptScore W2932069706C55493867 @default.
- W2932069706 hasConceptScore W2932069706C86803240 @default.
- W2932069706 hasConceptScore W2932069706C95444343 @default.
- W2932069706 hasFunder F4320320847 @default.
- W2932069706 hasFunder F4320332567 @default.
- W2932069706 hasFunder F4320337355 @default.
- W2932069706 hasIssue "21" @default.
- W2932069706 hasLocation W29320697061 @default.
- W2932069706 hasLocation W29320697062 @default.
- W2932069706 hasLocation W29320697063 @default.
- W2932069706 hasOpenAccess W2932069706 @default.